Showing 17,801 - 17,820 results of 18,095 for search '(( significant point decrease ) OR ( significant ((a decrease) OR (teer decrease)) ))', query time: 0.67s Refine Results
  1. 17801

    Algorithm training accuracy experiments. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  2. 17802

    Table 2_Long-term outcomes of platinum-based chemotherapy for T4 stage sinonasal adenoid cystic carcinoma.docx by Xinmao Song (5124035)

    Published 2025
    “…Besides, chemotherapy significantly decreased 10-year OS (27.9% vs. 58.8%, P = 0.034) compared with the no-chemotherapy group. …”
  3. 17803

    Table 1_Long-term outcomes of platinum-based chemotherapy for T4 stage sinonasal adenoid cystic carcinoma.doc by Xinmao Song (5124035)

    Published 2025
    “…Besides, chemotherapy significantly decreased 10-year OS (27.9% vs. 58.8%, P = 0.034) compared with the no-chemotherapy group. …”
  4. 17804

    Repeat the detection experiment. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  5. 17805

    Cardiac function. by Gerald Yu Liao (20490394)

    Published 2024
    “…<p><b>A.</b> C57BL/6J mice did not show age-related changes in LVMI (tibia). …”
  6. 17806

    Image 1_Long-term outcomes of platinum-based chemotherapy for T4 stage sinonasal adenoid cystic carcinoma.jpeg by Xinmao Song (5124035)

    Published 2025
    “…Besides, chemotherapy significantly decreased 10-year OS (27.9% vs. 58.8%, P = 0.034) compared with the no-chemotherapy group. …”
  7. 17807

    Detection network structure with IRAU [34]. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  8. 17808
  9. 17809

    Ablation experiments of various block. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  10. 17810

    Kappa coefficients for different algorithms. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  11. 17811

    The structure of ASPP+ block. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  12. 17812

    The structure of attention gate block [31]. by Yingying Liu (360782)

    Published 2025
    “…The research focuses on the advantages and problems of residual networks and depth-wise separable convolution modules, designs a new remote sensing image change detection model, and finally sets up experiments for verification. …”
  13. 17813

    ZIKV infection enriches the HLA Class I pathway in brain tumour cells. by Matt Sherwood (22530221)

    Published 2025
    “…Normalised enrichment score (NES) denotes the degree to which the enrichment increased (+) or decreased (-). GSEA analysis significance is defined by p ≤ 0.05 and FDR ≤ 0.25. …”
  14. 17814

    DataSheet1_Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing.pdf by Seungchan An (6256061)

    Published 2024
    “…Subcutaneous injection of humanized CXCL12 Ab significantly delayed AA onset in mice, and dorsal skin was analyzed. …”
  15. 17815

    Table1_Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing.xlsx by Seungchan An (6256061)

    Published 2024
    “…Subcutaneous injection of humanized CXCL12 Ab significantly delayed AA onset in mice, and dorsal skin was analyzed. …”
  16. 17816

    Table 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”
  17. 17817

    Image 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”
  18. 17818

    Image 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  19. 17819

    Table 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

    Published 2025
    “…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”
  20. 17820

    Image 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

    Published 2025
    “…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”